Modulations of the M. tuberculosis-specific IFN-gamma levels during anti-tuberculosis treatment in children

M. Losi, R. Markova, D. Goletti, R. Drenska, S. Carrara, Y. Todorova, O. Butera, F. Rumpianesi, M. Meacci, B. Meccugni, L. Richeldi, M. Amicosante (Modena, Rome, Italy; Sofia, Bulgaria)

Source: Annual Congress 2009 - Tuberculosis at different age groups
Session: Tuberculosis at different age groups
Session type: Thematic Poster Session
Number: 2493
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Losi, R. Markova, D. Goletti, R. Drenska, S. Carrara, Y. Todorova, O. Butera, F. Rumpianesi, M. Meacci, B. Meccugni, L. Richeldi, M. Amicosante (Modena, Rome, Italy; Sofia, Bulgaria). Modulations of the M. tuberculosis-specific IFN-gamma levels during anti-tuberculosis treatment in children. Eur Respir J 2009; 34: Suppl. 53, 2493

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IP-10 decreases during antituberculous treatment in children with active tuberculosis.
Source: Virtual Congress 2020 – Tuberculosis: part 2
Year: 2020




Changes of ESAT-6/CFP-10 – stimulated IFN-g and IL-2 production during specific anti-tuberculosis treatment in children
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009



Utility of antigen-specific IFN-gamma assays for monitoring of disease activity and efficacy of anti-TB treatment in HIV-/TB+ and HIV+/TB+ patients in Bulgaria
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006

Serum concentration of cytokines before and during treatment in patients with active tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002

Serum and r32kd induced cytokine levels and expression in tuberculosis patients and contacts
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

The increased production level of 15 cytokines associated with tuberculosis severity and patients’ responsiveness to therapy.
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019



Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Serum IL-10 and IL-12 level changes in tuberculosis
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Effect of isoniazid prophylaxis for latent TB on interferon-gamma response
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


Reduced expression of interferon stimulated genes in refractory asthma
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012

Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010

Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level
Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis
Year: 2003


Isoniazid hepatotoxicity associated with treatment of latent tuberculosis in patients on anti-TNF treatment
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Screening for latent TB using antigen-specific IP-10 response and the effect of prednisolon
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012



Effects of childhood asthma and inhaled corticosteroid treatment on EBC levels of IL-4 and TNF-α
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005

Characteristics of IL-12p70 and IL-12p40 serum level among active, latent, and contact with tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs
Source: Eur Respir J 2009; 34: 702
Year: 2009



New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5
Source: Eur Respir J 2001; 17: 499-506
Year: 2001